ChinaDaily Briefs

Daily Brief China: MiniMax, Eoptolink Technology , Lotus Horizon, ANTA Sports, Plover Bay Technologies, Junlebao Dairy Group, Ligent Technologies, XtalPi, Zhejiang IPLUSMOBOT Technology and more

In today’s briefing:

  • MiniMax (100 HK): Synthetic Expert Call Transcript (03 Sep 2026)
  • Aequitas: Eoptolink A/H Listing – Early Look – At What Could Be HK’s Largest 4Q Listing at >US$3bn
  • Lotus (6063 HK) Is A Bubble Stock. Expect An Unconditional Takeunder
  • Anta Sports (2020 HK): 1H26, Strategy Shift Beneath Steady Financials, 50% Upside
  • The Making of a Multibagger: What Plover Bay Teaches Us About Finding the Next One
  • Junlebao (君乐宝乳业) Pre-IPO: Tearsheet
  • Ligent (纳真科技) Pre-IPO: Tearsheet
  • Ligent Technologies IPO: The Investment Case
  • Primer: XtalPi (2228 HK) – Sep 2026
  • Zhejiang IPLUSMOBOT Technology (IPMBT HK): Synthetic Expert Call Transcript (03 Sep 2026)


MiniMax (100 HK): Synthetic Expert Call Transcript (03 Sep 2026)

By αSK SmartScripts

  • The post-lock-up liquidity overhang on MiniMax was cleared through a coordinated dual-tranche HKD 16 billion fundraise on July 10, 2026, which provided arbitrageurs the necessary stock borrow to delta-hedge the concurrent HKD 6.5 billion convertible bond, followed by a massive short squeeze driven by the Southbound Stock Connect inclusion.
  • MiniMax’s revenue mix has aggressively shifted to B-end enterprise and API services, which accounted for 63.4% of H1 2026 revenue. Despite an ARR reaching US$800 million by late August, gross margins remain constrained at 17.9% due to high GPU compute costs.
  • CEO Yan Junjie’s total salary sacrifice and the transfer of 5% of his personal equity stake serve as a crucial governance mechanism to align employee KPIs away from unhedged ARR growth and toward architectural efficiency and path-to-profitability.

Disclaimer: The following transcripts are synthetic, AI-generated on demand, and compiled exclusively from public data sources; no real-word experts were actually interviewed. This content is designed to highlight potential market mispricings, explore compelling lines of inquiry, and suggest strategic questions rather than present verified facts. All specific financial metrics and data points, including market shares, TAM, margins, and growth rates, are AI-estimated approximations. They may be inaccurate and must be independently verified.


Aequitas: Eoptolink A/H Listing – Early Look – At What Could Be HK’s Largest 4Q Listing at >US$3bn

By Sumeet Singh

  • Eoptolink Technology (300502 CH) one of the world’s largest optical transceiver manufacturers, aims to raise over >US$3bn in its H-share listing.
  • Eoptolink was one of the global leaders in 2025 in optical modules, with its products being in high demand for data centers.
  • In this note, we look at its past performance and other deal dynamics that might impact the listing.

Lotus (6063 HK) Is A Bubble Stock. Expect An Unconditional Takeunder

By David Blennerhassett

  • Construction subcontractor Lotus Horizon (6063 HK) is suspended pursuant to the Hong Kong Code on Takeovers and Mergers.
  • I expect Lotus will follow in WK Group (2535 HK) and Superland Group Holdings (368 HK)‘s footsteps, whereby the controlling family exits, triggering an unconditional takeunder. 
  • Loss-Making Lotus is a total bubble stock, up 457% since Feb , 750%+ in 12 months, and trading at 20x P/B. Are shell companies and reverse takeovers making a comeback?

Anta Sports (2020 HK): 1H26, Strategy Shift Beneath Steady Financials, 50% Upside

By Ming Lu

  • We have to admit that brand acquisitions are a sustainable path forward.
  • Domestically, the ANTA brand is placing increasing emphasis on online retail.
  • Internationally, Anta plans to open 1,000 stores in Southeast Asia.

The Making of a Multibagger: What Plover Bay Teaches Us About Finding the Next One

By Steven Chen

  • Plover Bay compounded because a specialist technology capability, mission-critical customer problem and capital-light model reinforced one another far beyond the original 5G thesis.
  • Its less visible advantage was organizational: long-tenured technical leadership, small independent teams and rapid customer feedback enabled adaptation across successive connectivity technologies.
  • The next Plover Bay may emerge from any industry where a small, overlooked company combines niche leadership, superior learning speed, attractive economics and a long reinvestment runway.

Junlebao (君乐宝乳业) Pre-IPO: Tearsheet

By Ke Yan, CFA, FRM

  • Junlebao, a formerly Mengniu-backed Chinese dairy producer, has filed its prospectus with the HKEX. CICC and MS are the joint sponsors.
  • We look at the company’s core segments, liquid dairy products and formula.
  • We then look at the company’s financial profile, margin pressure, pre-IPO valuation and investor backing.

Ligent (纳真科技) Pre-IPO: Tearsheet

By Ke Yan, CFA, FRM

  • Ligent, a Hisense-controlled optical transceiver and optical network terminal maker, has passed the HKEX listing hearing and is seeking a Main Board listing. Citi and CITIC are the joint sponsors.
  • We look at the company’s core segments: optical transceivers and optical network terminals.
  • We then look at the company’s financial profile, profit rebound, pre-IPO valuation and investor backing.

Ligent Technologies IPO: The Investment Case

By Arun George

  • Ligent Technologies (LGT HK) is an optical communication and connectivity products provider. It is seeking to raise US$800 million.     
  • In 2025, among all specialised optical transceiver manufacturers globally, Ligent ranked 5th in global optical transceiver revenue, with a market share of 4.0%.
  • The investment case is bullish as Ligent is a business executing well (share gains, strong growth, improving margins) in an industry benefiting from a structural growth theme.   

Primer: XtalPi (2228 HK) – Sep 2026

By αSK Primers

  • XtalPi (2228 HK) is a pioneer in TechBio and automated scientific research, integrating quantum physics algorithms, artificial intelligence, and high-throughput robotic wet laboratories to accelerate discovery in biopharmaceuticals and advanced materials.
  • The company demonstrated a sharp operational inflection in FY2025, with revenue expanding to RMB 870.46M (a >4.5x increase compared to FY2023), gross margins shifting from negative territory to 55.27%, and reported net income reaching RMB 134.21M.
  • Trading at a Price-to-Book multiple of 3.1x relative to an industry peer group averaging 4.0x to 6.0x, XtalPi provides institutional investors with a differentiated, high-growth play on industrial-scale laboratory automation and AI-driven scientific discovery.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Zhejiang IPLUSMOBOT Technology (IPMBT HK): Synthetic Expert Call Transcript (03 Sep 2026)

By αSK SmartScripts

  • Backlog-Driven Growth Illusion: Zhejiang IPLUSMOBOT’s massive 131.2% revenue growth in 2025 is structurally deceptive. While revenue spiked to 265.5 million RMB, new order growth was nearly flat, growing only 10.2% from 288 million RMB to 318 million RMB. This indicates the business was primarily clearing out a long-standing backlog of unaccepted, historical projects rather than winning new market demand.
  • Working Capital & “Circular Trade” Vulnerabilities: The company’s working capital is severely strained by customer concentration and highly unfavorable commercial terms. Its top five customers contribute over 55% of revenue. Most notably, its relationship with Customer F (who is also Supplier F) involves a circular trade where IPLUSMOBOT grants a massive 180-day credit period on sales but is forced to accept a 30-day credit period on procurement, draining cash.
  • The 18C Valuation Gap: To successfully list on the HKEX under the Chapter 18C specialist technology rules, IPLUSMOBOT needs to achieve a minimum market capitalization of 4 billion HKD (approximately 3.7 billion RMB). Its last C++ private round in January 2026 valued the company at 2.13 billion RMB, meaning it must secure a 62% valuation markup in a highly skeptical market, all while carrying 3.95 billion RMB in cumulative net losses over the past three and a half years and an ongoing cash-burning operating model.

Disclaimer: The following transcripts are synthetic, AI-generated on demand, and compiled exclusively from public data sources; no real-word experts were actually interviewed. This content is designed to highlight potential market mispricings, explore compelling lines of inquiry, and suggest strategic questions rather than present verified facts. All specific financial metrics and data points, including market shares, TAM, margins, and growth rates, are AI-estimated approximations. They may be inaccurate and must be independently verified.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars